Keyphrases
Antifungal Drugs
100%
Onychomycosis
100%
Susceptibility Testing
100%
Aspergillus Versicolor
100%
Versicolor
60%
Toenail
40%
Antifungal Agents
40%
Terbinafine
40%
Fungal Infection
20%
Etiological Agents
20%
Local Treatment
20%
Increasing Prevalence
20%
Predisposing Factors
20%
Scopulariopsis Brevicaulis
20%
Amphotericin B
20%
Itraconazole
20%
Fluconazole
20%
In Vitro Susceptibility
20%
Systemic Antifungals
20%
Topical Antifungals
20%
Big Toe
20%
Ketaconazole
20%
Toenail Onychomycosis
20%
Griseofulvin
20%
Emergent Pathogen
20%
Medicine and Dentistry
Antifungal Agent
100%
Onychomycosis
100%
Aspergillus versicolor
100%
In Vitro
40%
Toe
40%
Terbinafine
40%
Prevalence
20%
Infection
20%
Mycosis
20%
Local Therapy
20%
Disease Predisposition
20%
Amphotericin B
20%
Fluconazole
20%
Toenail Onychomycosis
20%
Systemic Antifungal Agent
20%
Pathogen
20%
Itraconazole
20%
Griseofulvin
20%
Pharmacology, Toxicology and Pharmaceutical Science
Antifungal Agent
100%
Onychomycosis
100%
Aspergillus versicolor
100%
Mould
40%
Terbinafine
40%
Itraconazole
20%
Scopulariopsis Brevicaulis
20%
Systemic Antifungal Agent
20%
Griseofulvin
20%
Infectious Agent
20%
Infection
20%
Prevalence
20%
Mycosis
20%
Disease Predisposition
20%
Amphotericin B
20%
Fluconazole
20%
Toenail Onychomycosis
20%
Immunology and Microbiology
Aspergillus versicolor
100%
Minimum Inhibitory Concentration
66%
Mould
66%
Terbinafine
66%
Toe
66%
Infectious Agent
33%
Prevalence
33%
Scopulariopsis Brevicaulis
33%